Want to see SE:BINV full AI Analyst Report?
Compare BioInvent International AB (BINV) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SE:BINVBioInvent International AB | SEK 5.43 | SEK 357.32M | -0.73 | -83.69% | ― | SE:BINV | ||||
| SE:ATORXAlligator Bioscience AB | SEK 0.01 | SEK 35.32M | -0.01 | -96.20% | ― | SE:BINV vs SE:ATORX | ||||
| SE:ONCOOncopeptides AB | SEK 1.67 | SEK 721.66M | -2.14 | -68.28% | ― | SE:BINV vs SE:ONCO | ||||
| SE:ELICElicera Therapeutics AB | SEK 2.66 | SEK 177.19M | -7.51 | -54.73% | ― | SE:BINV vs SE:ELIC | ||||
| SE:IMMUImmunicum AB | SEK 5.50 | SEK 348.89M | -3.07 | -25.68% | ― | SE:BINV vs SE:IMMU | ||||
| SE:CANTACantargia AB | SEK 1.60 | SEK 451.68M | 2.35 | -53.02% | Moderate Buy | SE:BINV vs SE:CANTA |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SE:BINV | BioInvent International AB | 5.43 | -28.47 | -83.98% | |
| SE:ATORX | Alligator Bioscience AB | 0.01 | -0.38 | -97.42% | |
| SE:ONCO | Oncopeptides AB | 1.67 | -3.75 | -69.16% | |
| SE:ELIC | Elicera Therapeutics AB | 2.65 | -3.44 | -56.47% | |
| SE:IMMU | Immunicum AB | 5.50 | -1.89 | -25.58% | |
| SE:CANTA | Cantargia AB | 1.60 | -1.97 | -55.13% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts